Treatment of Methicillin-Resistant Staphylococcus aureus Infections with a Minimal Inhibitory Concentration of 2 μg/mL to Vancomycin: Old (Trimethoprim/Sulfamethoxazole) versus New (Daptomycin or Linezolid) Agents

Daptomycin for Methicillin-Resistant Staphylococcus aureus Bloodstream Infection and Elevated Vancomycin Minimum Inhibitory Concentrations: Has the Time Come?

(2011) A. Weston et al.   CLINICAL INFECTIOUS DISEASES

Does Trimethoprim-Sulfamethoxazole Prophylaxis for HIV Induce Bacterial Resistance to Other Antibiotic Classes?: Results of a Systematic Review

(2011) E. L. Sibanda et al.   CLINICAL INFECTIOUS DISEASES

A Randomized, Double-Blind Phase 2 Study Comparing the Efficacy and Safety of an Oral Fusidic Acid Loading-Dose Regimen to Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections

(2011) J. Carl Craft et al.   CLINICAL INFECTIOUS DISEASES

Daptomycin Versus Vancomycin for Bloodstream Infections Due to Methicillin-Resistant Staphylococcus aureus With a High Vancomycin Minimum Inhibitory Concentration: A Case-Control Study

(2011) C. L. Moore et al.   CLINICAL INFECTIOUS DISEASES

Characterization of Global Patterns and the Genetics of Fusidic Acid Resistance

(2011) David J. Farrell et al.   CLINICAL INFECTIOUS DISEASES

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary

(2011) Catherine Liu et al.   CLINICAL INFECTIOUS DISEASES

Impact of Vancomycin Exposure on Outcomes in Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines Suggested Targets

(2011) R. Kullar et al.   CLINICAL INFECTIOUS DISEASES

Growing Prevalence of Vancomycin-Resistant Enterococcus faecalis in the Region with the Highest Prevalence of Vancomycin-Resistant Staphylococcus aureus

(2011) Kayoko Hayakawa et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Relationship between the MIC of vancomycin and clinical outcome in patients with MRSA nosocomial pneumonia

(2011) Eun Young Choi et al.   INTENSIVE CARE MEDICINE

Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004–2009

(2011) Stephen P. Hawser et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations

(2011) Natasha E. Holmes et al.   JOURNAL OF INFECTIOUS DISEASES

Trimethoprim-sulfamethoxazole Therapy for Children With Acute Osteomyelitis

(2011) Allison F. Messina et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Dissemination of an Enterococcus Inc18-Like vanA Plasmid Associated with Vancomycin-Resistant Staphylococcus aureus

(2010) W. Zhu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Systematic Review and Meta-Analysis of the Significance of Heterogeneous Vancomycin-IntermediateStaphylococcus aureusIsolates

(2010) Sebastiaan J. van Hal et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Hemorrhage During Warfarin Therapy Associated With Cotrimoxazole and Other Urinary Tract Anti-infective Agents

(2010) Hadas D. Fischer et al.   ARCHIVES OF INTERNAL MEDICINE

Trimethoprim-Sulfamethoxazole–Induced Hyperkalemia in Patients Receiving Inhibitors of the Renin-Angiotensin System

(2010) Tony Antoniou   ARCHIVES OF INTERNAL MEDICINE

Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naïve patient—a review of the literature

(2010) S. J. van Hal et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Clinical Outbreak of Linezolid-Resistant Staphylococcus aureus in an Intensive Care Unit

(2010) Miguel Sánchez García   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study

(2010) E. Goldberg et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Trimethoprim-Sulfamethoxazole or Clindamycin for Community-Associated MRSA (CA-MRSA) Skin Infections

(2010) C. R. Frei et al.   Journal of the American Board of Family Medicine

Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health‐System Pharmacists, and the Society of Infectious Diseases Pharmacists

(2009) Michael J. Rybak et al.   CLINICAL INFECTIOUS DISEASES

Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008

(2009) R Phillip Dellinger et al.   CRITICAL CARE MEDICINE

Clinical Features of Heteroresistant Vancomycin-IntermediateStaphylococcus aureusBacteremia versus Those of Methicillin-ResistantS. aureusBacteremia

(2009) Yasmin Maor et al.   JOURNAL OF INFECTIOUS DISEASES